MedPath

Prospective study for evaluating hepatic steatosis using Ultrasound-guided attenuation parameter (UGAP) and Controlled Attenuation Parameter (CAP) by comparison with MRI-determined proton density fat fraction (PDFF)

Not Applicable
Recruiting
Conditions
chronic liver disease
Registration Number
JPRN-UMIN000041902
Lead Sponsor
Yokohama City University School of Medicine Department of Gastroenterology and Hepatology
Brief Summary

GAP is useful compared to CAP

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients without claustrophobia 2.Patients without magnetic substance or tattoo 3.Patients without pacemakers 4.Patients who are pregnant 5.Patients judged as inappropriate for the study by the study responsibility (share) physician.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath